Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SDK1 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-10 |
mRNA | CBFA2T2 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
mRNA | DNMT3A | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-10 |
mRNA | ZNF606 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-10 |
mRNA | CD101 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
mRNA | RASGRP2 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-09 |
mRNA | KIAA0408 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-09 |
mRNA | BEND5 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | ZNF337 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |